TEL AVIV, Israel, Sept. 25, 2017 /PRNewswire/ -- CannaTech UK
is pleased to announce that MGC Pharma, an Australian based Medical Grade Cannabis company with global operations, will be
sponsoring the CannaTech UK Innovation Summit, the first ever conference on Medical Cannabis in the UK.
MGC Pharmaceuticals is a publicly traded (ASX: MXC) BioPharma company with a focus on Phytocannabinoid Medications. MGC Pharma
has created a seamless, highly-supervised supply chain, from growing through to API level extraction, with global operations
providing proprietary Phytocannabinoid formulations to companies, consumers, researchers and patients worldwide.
MGC Pharma's medications (currently in clinical trials) for treatment areas such as Neurology, Oncology and Palliative Care,
all emerge from this pipeline, with the list continuing to grow as more research materializes. With research activities in
various fields in Europe, Australia and Israel, MGC Pharma intends to impact global health and wellness via the judicious use of Phytocannabinoid
across multiple markets.
CannaTech UK will provide a platform to enable the identification and incubation of world-class innovative solutions for the
Cannabis industry. The main event will take place on October 26 at Th e Old Truman Brewer y, and will be
preceded on October 25 by a pre-event investor symposium dedicated to understanding the
ins-and-outs of investing in the Medical Cannabis industry.
Dr Neubauer and Ron Lipsky from MGC Pharmaceuticals will also be speaking at the conference. Dr
Neubauer recently conducted a clinical study to assess the efficacy of a Medical Cannabis formulation in children with
treatment-resistant epilepsy. Ron Lipsky is the Manager of Business Development and International
Relations at MGC Pharma and has been working for over 10 years in the Medical Cannabis industry, primarily in Israel.
"We are extremely happy to be sponsoring CannaTech UK. As one of the world's leading medical grade Cannabis companies
working to improve global health, MGC Pharma sees CannaTech UK as a key venue for reaching the European market, which is poised
to grow exponentially, reaching billions of dollars in the next decade. We hope that MGC's speakers will contribute much to both
the scientific and financial discourse at the event," said Roby Zomer, CEO & Executive
Director of MGC Pharma.
To learn more about the CannaTech UK Innovation Summit, purchase tickets and subscribe to speakers lists & event updates,
click here. To learn about iCAN,
the Summit's organizers, visit their website here.
To learn more about MGC Pharma, visit their website here.
Contact Laura Kam, laura@kamgs.com, +972-54-806-8613 for further information, to RSVP and to arrange interviews with the
conference organizers and speakers.
View original content:http://www.prnewswire.com/news-releases/mgc-pharmaceuticals-set-to-sponsor-and-speak-at-cannatech-uk-the-first-ever-medical-cannabis-conference-in-london-300524978.html
SOURCE MGC Pharmaceuticals